← Eichor
Study identifier: NCT05903560 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Radial Versus Femoral Access For Thrombectomy in Patients With Acute Basilar Artery Occlusion

Condition: Acute Ischemic Stroke  ·  Sponsor: Jinling Hospital, China

PhaseNA
Planned participants386
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Stroke is one of the most important diseases endangering the health and quality of life of Chinese people. Acute ischemic stroke (AIS) is commonly caused by cerebrovascular stenosis or occlusion. The most effective treatment for AIS is timely and successful angiographic reperfusion. Due to the large diameter and obvious positioning of bilateral femoral arteries, the transfemoral artery (TFA) using Seldinger's technique has been the most commonly used approach for endovascular treatment. However, recent studies have suggested that the radial artery is an ideal puncture site for cerebrovascular intervention. Small sample studies have confirmed that endovascular recanalization for acute anterior circulation large vessel occlusion via TRA has been safe and effective. Still, there are some complex approaches needed to be converted to TFA. There has been no difference in total operation duration and fluoroscopy time between TRA and TFA, but the TRA group had higher radiation dose and shorter hospital stays than the TFA group. In addition, TRA tends to be more convenient than TFA, especially for posterior circulation lesions. However, the current studies are based on a single center with a small sample size, and there has been still a lack of large-sample randomized controlled experiments to verify the safety and effectiveness of posterior endovascular recanalization via TRA.

This description comes directly from the study's public registry record.

Talk to the study team

Rui Liu, MD  ·  +86 2584801861  ·  liurui8616@163.com

Xinfeng Liu, MD  ·  +86 2584801861  ·  xfliu2@vip.163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Department of Neurology, Jinling HospitalNanjing, Jiangsu, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05903560